Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Harvard Business School
Fish and Richardson
Johnson and Johnson
Accenture
Healthtrust
McKesson
Deloitte
Fuji

Generated: May 27, 2018

DrugPatentWatch Database Preview

MYIDYL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Myidyl, and when can generic versions of Myidyl launch?

Myidyl is a drug marketed by Usl Pharma and is included in one NDA.

The generic ingredient in MYIDYL is triprolidine hydrochloride. There are thirteen drug master file entries for this compound. Additional details are available on the triprolidine hydrochloride profile page.
Summary for MYIDYL
Drug patent expirations by year for MYIDYL
Medical Subject Heading (MeSH) Categories for MYIDYL
Synonyms for MYIDYL
(E)-2-(1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)pyridine
(E)-2-(3-(pyrrolidin-1-yl)-1-p-tolylprop-1-enyl)pyridine
(E)-2-[3-(1-Pyrrolidinyl)-1-p-toluenepropenyl]pyridine
(E)-2-[3-(1-Pyrrolidinyl)-1-p-tolylpropenyl]pyridine hydrochloride
1-((E)-3-Pyridin-2-yl-3-p-tolyl-allyl)-pyrrolidinium
2-((E)-3-Pyrrolidin-1-yl-1-p-tolyl-propenyl)-pyridine
2-(3-(pyrrolidin-1-yl)-1-p-tolylprop-1-enyl)pyridine
2-(3-Pyrrolidin-1-yl-1-p-tolyl-propenyl)-pyridine
2-[(1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridine
2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ium-1-ylprop-1-enyl]pyridine chloride
2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine
2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine hydrochloride
2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine
2L8T9S52QM
486-12-4
486T124
550-70-9 (mono-hydrochloride)
6138-79-0 (mono-hydrochloride, mono-hydrate)
AB00053563_14
AB00053563-02
AB00053563-13
AC1NR02Y
ACM486124
ACTAHIST
Actidil
Actidil (TN)
AKOS027460758
ALLERFED
AN-45232
BDBM50292411
BIDD:GT0569
BIM-0025383.P001
BPBio1_000116
BRD-K11742128-003-05-1
BSPBio_000104
BSPBio_002255
C19H22N2
CAS-486-12-4
CBEQULMOCCWAQT-WOJGMQOQSA-N
CCG-12422
CCRIS 7212
CHEBI:84116
CHEMBL855
CORPHED
D08648
D0E8CI
DB00427
DSSTox_CID_3718
DSSTox_GSID_23718
DSSTox_RID_77161
DTXSID3023718
EINECS 207-627-0
GTPL1228
Histafed
HMS2089M21
HSDB 6316
IDI1_000297
KB-105517
L000901
Lopac0_001130
LS-1293
MolPort-003-182-178
MYFED
Myidil (TN)
NCGC00024714-02
NCGC00024714-03
NCGC00024714-04
NCGC00024714-05
NCGC00024714-06
NCGC00024714-07
NCGC00024714-08
NCGC00024714-11
NCI-C61450
Prestwick2_000262
Prestwick3_000262
Pyridine, 2-((1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl)-, hydrochloride (1:1)
Pyridine, 2-((1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, monohydrochloride
Pyridine, 2-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, (E)-
Pyridine, 2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)-, (E)-
SBI-0025383.P004
SCHEMBL4905
Spectrum5_001467
T 6764
Tox21_110919
Tox21_110919_1
trans-1-(2-Pyridyl)-3-pyrrolidino-1-p-tolylprop-1-ene
trans-1-(4-Methylphenyl)-1-(2-pyridyl)-3-pyrrolidinoprop-1-ene
trans-2-(3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)pyridine
TRILITRON
TRIPHED
Tripolidina
Tripolidina [INN-Spanish]
Triprolidin
triprolidine
Triprolidine (INN)
Triprolidine [INN:BAN]
Triprolidine HCL
Triprolidine Monohydrochloride
Triprolidine Monohydrochloride, Monohydrate
Triprolidinum
Triprolidinum [INN-Latin]
Tripyrolidine
UNII-2L8T9S52QM
Venen (TN)
ZINC12503099

US Patents and Regulatory Information for MYIDYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Usl Pharma MYIDYL triprolidine hydrochloride SYRUP;ORAL 087963-001 Jan 18, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fuji
Healthtrust
Teva
Colorcon
Harvard Business School
Cantor Fitzgerald
Express Scripts
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.